Pharmaceuticals, Biotechnology and Life Sciences
Schreiner MediPharm will showcase its new Smart Blister Wallet, which is extendable from 32 to up to 64 cavities, at this year’s Pharmapack in Paris, on May 18 and 19.
Schreiner MediPharm has developed a compact Booklet-Label for a needle protection system used in an international phase III clinical trial conducted by pharmaceutical corporation Sanofi.
Schreiner MediPharm has launched a new tamper-evident security concept for luer-lock syringes: Cap-Lock features a combination of a cap adapter and label that firmly seals prefilled syringes and reliably indicates any first opening.
A new forensic authentication feature for pharmaceutical labels is offered by Schreiner MediPharm in cooperation with Applied DNA Sciences: SigNature® DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect their products against counterfeiting and patients against potential health risks. DNA markers are deemed to be impossible to counterfeit and recognized as forensic authentication evidence in courts of law.
Schreiner MediPharm developed the Patch-Safe specialty label for PS Marketing & Outsourcing GmbH, to be used for safe disposal of patches containing active ingredients.
Schreiner MediPharm’s trade fair presentation at Pharmapack 2019 in Paris will be fully focused on smart packaging solutions. On February 6 and 7, in Hall 7.2, Booth B32, the specialist for innovative labels and marking solutions with value-added benefits will showcase its latest product development in the field of digital therapy monitoring: The new “Smart Vial Kit” enables electronic tracking and monitoring of medication dispensing and intake.